- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02545686
Effect of CPAP on Breath Hold and Chest Movement in Normal Volunteers (CPAP_normal)
Use of the Real-time Position Management (RPM) to Measure the Effects of Continuous Positive Airway Pressure (CPAP) on Duration of Breath Hold and Diaphragm Motion in Normal Volunteers
Study Overview
Status
Detailed Description
CPAP is a non-invasive ventilation technique that is commonly used to treat sleep apnea. Using a small air-pump, tubing and facemask, it provides a constant stream of pressurized air to the upper airways and lungs. Some of the physiological effects noted during CPAP are hyperinflation of the lungs, stabilizing and flattening of the diaphragm, and decrease in tidal volume. The effects on duration of breath hold are unknown. During radiation treatment, these effects are expected to reduce tumor and organ motion which reduces the volume of normal tissue being irradiated and also creates favorable treatment geometry by moving the heart away from the anterior chest wall. An important advantage of CPAP compared to other techniques is that active patient cooperation is not required. The potential exists to combine use of CPAP with other respiratory management techniques such as breath hold and improve overall effectiveness. When used in sleep apnea it is well tolerated and poses little risk to patients. There are no published reports of the use of CPAP in radiation therapy.
In initial studies the Varian RPM system was used to assess respiratory motion with and without CPAP for patients receiving radiation therapy. This commercially available, non-invasive system works by directing an infrared beam onto an infrared motion detector that is placed on the patients' upper abdomen. The detector records the change in abdomen position that occurs with respiration as a change in amplitude of the detector position. Interventions that effect respiration will be recorded by an increase or decrease in the amplitude of the detector motion. When used in breath hold, the detector remains in a fixed position with a very narrow gating window.
Based on initial experience with the RPM system, it has been found that approximately 1 hour of CPAP use is required to reduce diaphragm motion. Although early results are favorable using this approach, it is not certain that this is the best or most efficient method of use for all patients. The use of CPAP combined with breath hold techniques has not been studied.
The objectives of this study are to use the RPM system in normal volunteers to:
- Study the effects of CPAP on diaphragm motion to allow better optimization for the use of CPAP as a respiratory management technique during free breathing.
- Determine the feasibility of use of CPAP as a respiratory aid for use in patients treated with breath hold techniques. Determine the effects of CPAP on duration; reproducibility and tolerance of the breath hold technique.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ramat Gan, Israel, 52621
- Recruiting
- Sheba Medical Center
-
Contact:
- Yaacov R Lawrence, MBBS MA MRCP
- Phone Number: 97235304410
- Email: Yaacov.Lawrence@sheba.health.gov.il
-
Contact:
- Hila Gnessin
- Phone Number: 035307034
- Email: Hila.Gnessin@sheba.health.gov.il
-
Principal Investigator:
- Zvi Symon, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Normal volunteers without a cancer diagnosis.
No contraindications to the use of CPAP
- Facial injury or deformity preventing wearing facial mask
- Recurrent vomiting
- Chronic cough with phlegm
- Previous pneumothorax
- Facial lacerations or fractures
- Recent tracheal or esophageal anastomosis
- Recent GI surgery (last 90 days).
- 18-90 years of age
- Ability to sign informed consent
- Hebrew or English speakers
Exclusion Criteria:
Contraindications to CPAP
- Facial injury or deformity preventing wearing facial mask
- Recurrent vomiting
- Chronic cough with phlegm
- Previous pneumothorax
- Facial lacerations or fractures
- Recent tracheal or esophageal anastomosis
- Recent GI surgery (last 90 days).
- Under age 18 or above age 90 years
- Inability to sign informed consent
- Members of special populations (mental illness, pregnant women, prisoners, not legally competent).
- History of severe active restrictive or obstructive lung disease (as defined as at least one hospitalization over previous two years)
- Any medical condition requiring an inpatient hospitalization for more than 72 hours over the previous 2 years, aside from elective surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: one
this is a single arm study. All subjects treated the same way, and undergo four interventions:
|
While subject is breathing normally, determine chest wall movement (via RPM waveform) with free breathing, over the course of half an hour.
While subject is breathing normally, subject will perform a moderate and a deep inspiratory breath hold.
Duration, reproducibility and tolerance of deep inspiratory breath hold will be recorded.
While subject is breathing via CPAP machine, determine chest wall movement (via RPM waveform) with free breathing, over the course of half an hour.
While subject is breathing via CPAP machine, subject will perform a moderate and a deep inspiratory breath hold.
Duration, reproducibility and tolerance of deep inspiratory breath hold will be recorded.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Chest wall motion amplitude
Time Frame: 2 hours
|
Amplitude of chest wall motion, measured in centimeters.
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of breath hold
Time Frame: 2 hours
|
Length (in seconds) that are subjects able to hold their breath.
|
2 hours
|
|
Reproducibility of breath hold depth
Time Frame: 2 hours
|
When 'breath hold' is performed three consecutive times, ascertain if it performed to the same depth each time.
Measured in centimeters.
|
2 hours
|
|
Respiratory rate
Time Frame: 2 hours
|
Number of breaths per minute.
|
2 hours
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SHEBA-15-2364-YL-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on Chest wall movement assessment without CPAP
-
Second Affiliated Hospital, School of Medicine,...RecruitingBreast NeoplasmsChina
-
Riphah International UniversityNot yet recruiting
-
Guy's and St Thomas' NHS Foundation TrustUniversity of Oxford; Engineering and Physical Sciences Research Council, UKCompleted
-
Bahçeşehir UniversityCompletedLower Extremity Problem | Balance Disorders | Foot InjuryTurkey
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Hospital Universitari de BellvitgeInstitut d'Investigació Biomèdica de Bellvitge; University of Barcelona; Hospital...Not yet recruitingObesity | Atypical Endometrial Hyperplasia | Endometrial Cancer | Endometrial Cancer Stage I | Obesity & Overweight | Endometrial Intraepithelial Neoplasia | Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I | BMI>40 | Obesity Grade III